Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
Veterinary and Comparative Oncology|March 13, 2012
Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotypeA Cervantes-Arias, L Y Pang, D J ArgyleThe Journal of Small Animal Practice|January 19, 2006
The in vitro effects of piroxicam and meloxicam on canine cell linesC Knottenbelt, G Chambers, E Gault, et al.DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1995
The isolation and sequence of canine interleukin-2S P Dunham, D J Argyle, D E OnionsVeterinary and Comparative Oncology|April 22, 2009
Feline epitheliotrophic T-cell lymphoma with paraneoplastic eosinophilia - immunochemotherapy with vinblastine and human recombinant interferon alpha(2b)T A Cave, E A Gault, D J ArgyleImmunogenetics|June 25, 1999
Cloning, sequencing, and characterization of dog interleukin-18D J Argyle, C McGillivery, L Nicolson, et al.Veterinary and Comparative Oncology|August 19, 2011
Development of a questionnaire assessing health-related quality-of-life in dogs and cats with cancerS Lynch, K Savary-Bataille, B Leeuw, et al.Veterinary and Comparative Oncology|January 13, 2012
Flow cytometric techniques for detection of candidate cancer stem cell subpopulations in canine tumour modelsT M Blacking, M Waterfall, K Samuel, et al.Gene|August 3, 2001
Molecular cloning and characterization of canine metalloproteinase-9 gene promoterS E Campbell, L Nasir, D J Argyle, et al.Journal of Comparative Pathology|February 18, 2014
Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumoursL Ressel, R W Else, A Poli, et al.Veterinary and Comparative Oncology|September 17, 2009
Inhibition of telomerase in canine cancer cells following telomestatin treatmentS Long, D J Argyle, E A Gault, et al.Pageof 7